Life Sciences consulting
Accelerating adoption of innovation
CF is a leading consultancy dedicated to making an enduring impact on health and healthcare. The Life Sciences Practice partners with pharmaceutical and biotech organisations to accelerate the adoption of innovation—ensuring new products and services reach patients faster and more equitably.
Our credentials
Experts in Health
Every CF consultant brings deep, real-world experience in health. Health is complex—clients deserve true experts.
Trusted advisors
Recognised by the Financial Times as a Gold-rated consultancy for Healthcare & Life Sciences, CF is one of just four firms to achieve this distinction.
Unrivalled data access
Instant access to longitudinal, record-level data for 57 million people in England, with the ability to securely access and analyse data across the UK and beyond.
Partnership
CF works alongside clients as a trusted partner, building solutions together and supporting teams at every stage.
Impact across the sector
We have extensive experience of collaborating with top life science companies, including pharma, biotech, medical devices and diagnostics. By combining deep insights into health systems with cutting-edge market research, real-world evidence, and strategic digital solutions, we accelerate the adoption and performance of innovations.
We also create optimal policy conditions for healthcare advancements through evidence-based thought leadership, taking a proactive stance on key issues. This comprehensive, 360 approach aids clients in improving uptake of technologies, for the benefit of patients everywhere.
Contact us to discuss how CF can support your evidence strategy and market access goals.
Our expert team
Ben Richardson
Managing Partner, Life Sciences
Ben Richardson
Over the last two decades Ben has worked across with health systems and life sciences companies on multiple continents. He has worked from national to local levels of health systems on strategy, transformation and development. He has worked in many areas including primary care, diabetes, cardiovascular, cancer, mental health as well as population health management more broadly.
Since 2014 he has supported the development of CF as an award-winning healthcare company operating in management consulting and data services and products.
Over the past two years Ben has led CF work to use data to support the UK’s response to Covid, vaccination of the country, recovery and addressing health inequalities.
Ben’s main focus now is supporting life sciences companies with the uptake of innovation in health systems and in enabling the use of data and digital to transform care and improve outcomes.
Prior to CF, Ben was a Senior Partner at McKinsey, where he served healthcare clients all over the world and led Integrated Care across Europe.
Ben is originally from Canada, and studied at both Princeton and Harvard. Outside of his work, he is an occasional cyclist, a consistent wine enthusiast, and a lover of travel and spending time on the water and in the outdoors.
Jo Andrews
Partner & Chief Medical Officer, London and Europe
Jo Andrews
Jo has led clinical services at a regional level, necessitating broad stakeholder engagement, and major service reconfigurations across sites to achieve service sustainability and clinical standards.
At CF, Jo’s major areas of interest are clinical strategy development, pathway and transformation, and workforce planning. Engaging and developing clinical leaders is at the heart of his approach to each of these, and improving the lives of patients and staff in healthcare is what energises him at work.
Away from CF, Jo is a keen cook, enthusiastic member of his local amateur dramatic society and reluctant follower of Tottenham Hotspur. He lives in Sussex with his wife and adult sons, as well as an assortment of animals who regularly appear on conference calls.
Kevin Densmore
Chief Technology Officer
Kevin Densmore
Kevin is a Chief Technology Officer, spearheading initiatives that leverage data and innovation to create impactful outcomes for our clients. He brings with him a deep commitment to the transformational power of AI underpinned by decades of experience in data analytics and technology consulting.
Kevin boasts more than 20 years’ of cross-industry experience, including health and life sciences. He has led and delivered cost reduction tracking in hospital systems as well as synergy capture and carve-outs for multinational pharmaceutical companies in addition to running data management and analytics engagements. At PwC, he also played a central role in the firm’s partnership with Palantir and in the firm’s own digital, data, and AI enablement journey.
Ioannis Katsoulis
Director, Life Sciences
Ioannis Katsoulis
Ioannis is Director for the CF Life Sciences practice, bringing over 12 years of experience in global market access, pricing, and health policy research, with a strong track record of delivering strategic insights across top pharmaceutical and biotech companies. Throughout his consulting career, Ioannis partnered with various functional teams to optimise the value proposition of therapies by demonstration of benefits for patients and healthcare systems.
Most recently, Ioannis served as Associate Principal at IQVIA, leading value communications and pricing engagements across therapy areas. Prior to IQVIA, he held roles of increasing responsibility at different consultancies including Evidera and ICON, where he developed health technology assessment (HTA), market access and pricing insights for medicines across their lifecycle. His work has informed evidence generation plans, launch readiness, and global market access and pricing strategy.
His expertise spans evidence generation planning and synthesis, real-world evidence studies, and strategic payer and physician key opinion leader engagements across major global markets, with a focus on the EU4 markets, the UK, US, China and Japan. His published work covers a broad range of topics on the use of real-world data for HTA and payer decision-making reflecting a commitment to advancing evidence-based policy and strategic market access for innovative therapies.
Yemi Oviosu
Senior Manager
Yemi Oviosu
Yemi is a Senior Manager with a background in technology strategy, IT operating model and organisation design and technology implementation. His experience across Life Sciences and Healthcare includes developing value propositions for digital health technologies, evaluating the implementation of AI/ML technologies in NHS Trusts and developing workforce supply and demand modelling across the NHS.
Yemi enjoys keeping fit by playing and coaching football regularly.
Neel Desai
Senior Consultant
Neel Desai
Neel is a Senior Consultant at CF who regularly utilises his pharmacist experience to support clients across the health systems and life sciences arms of CF. Neel has extensive knowledge of data, and is well versed in stakeholder engagement, project management and strategy development for the public and private sectors respectively. Neel holds a Ph.D. in pharmaceutical drug product development and a Master’s in Pharmacy, both from University College London (UCL). Neel continues to be a UK registered pharmacist.
Beena Mistry
Consultant
Beena Mistry
Joanna Craven
Data Operations Manager
Joanna Craven
Jo brings a research-driven approach to solving complex data challenges across industries.
Alisa Kamynina
Consultant
Alisa Kamynina
Alisa is a Consultant at CF, with a PhD in cardiovascular research and over a decade of expertise in life sciences. Before moving into consultancy, Alisa spent more than ten years in academia, conducting research on cardiovascular disease, hypertension, heart failure, and metabolic conditions such as obesity and diabetes. This background gives her a strong foundation in translating complex data and insights into practical solutions for healthcare challenges. Now in her consultancy role, Alisa focuses on supporting healthcare systems and life sciences organisations with evidence-based strategies. She has a particular interest in integrating research and data-driven approaches to improve patient outcomes and advance innovative therapies and care delivery.
Outside of work, Alisa enjoys rock climbing, taekwondo, and learning how to sail.
Madison Earle
Business Development Manager
Madison Earle
Madison is the Business Development Manager for Life Sciences. She is a Harvard University graduate with a concentration in Neuroscience and a secondary in Global Health & Health Policy.
Her role as CF will be focusing on strategic growth initiatives and partnership development.
Advisors
Haseeb Ahmad
Life Sciences Advisor
Haseeb Ahmad
Haseeb has over 25 years of life sciences leadership experience and a distinguished record of creating multi-billion dollar brands from primary care to rare disease, across mature and growth markets. He was most recently President for Novartis Europe having previously been President for Novartis Gene Therapies in the US. Prior to this, he was the Global Head of Value & Access and Commercial Development at Novartis and then Managing Director of Novartis UK, Ireland & Nordics. While at Novartis, Haseeb also acted as Government Advisor for Innovation Expert Group and acted as President and Chairman for ABPI prior to that. Before joining Novartis, he held a long career with MSD including country Managing Director roles in Ireland and Greece.
Throughout his career, Haseeb has built and led high-performing teams including at leading pharmaceutical companies. He is also a vocal advocate and industry ambassador for expanding access to innovative medicines.
Dorinda Hickey
Life Sciences Advisor
Dorinda Hickey
Dorinda has over 15 years’ consulting experience as a market access specialist; with expertise in pharmaceutical pricing and reimbursement, healthcare policy analysis, advocacy, payer engagement and value communications.
Prior to consulting Dorinda had a long career at Novartis where she held positions in business unit and country management, including Head of Oncology and Dermatology for Novartis UK, Head of Business Intelligence and Director of Healthcare Marketing. She has broad consulting and corporate experience in market access, marketing strategy and clinical development in a variety of therapy areas including Haematology, Endocrinology, Neurology, Mental Health, Respiratory Medicine, Cardiology, Organ Transplantation and Infectious Diseases.
Dorinda has developed industry leading mass market promotional campaigns and award winning programmes in the areas of Dermatology and Sexual Health. She has an MSc in Health Economics from the London School of Economics and a PhD in Haematology from Trinity College Dublin.
Gary Ford
Life Sciences Advisor
Gary Ford
Gary is an internationally renowned clinical researcher whose research has transformed the care of stroke patients in the NHS and worldwide, developing the Face Arm Speech Test and leading implementation of thrombolysis and thrombectomy for stroke. He is one of seven NIHR Research Legends, as well as a chair on multiple national academic institutes. Gary has extensive knowledge of health and research ecosystems with skills to respond rapidly to local and national priorities.
Dr Oliver Harrison
Life Sciences Advisor
Dr Oliver Harrison
Oliver is a health technology leader; he builds high-performing teams and has a unique track-record delivering business performance and driving health innovation from concept to commercialisation to multinational scale. With over two decades of experience in digital transformation, and healthcare AI, he brings a cutting-edge and mission-driven approach to addressing mental health challenges.
As an academic psychiatrist, Oliver brings deep clinical and technical knowledge, and as a Certified Public Health Expert, he prioritises data-driven strategies, and user-centred design to create impactful healthcare innovations and business success.
Dr Steve Laitner
Life Sciences Advisor
Dr Steve Laitner
Steve is a General Practitioner with a Public Health and Clinical Leadership background. He was an architect of the Accountable Lead Provider model whilst working at the Department of Health, where he was also National Clinical Lead for Shared Decision Making.
His work also covers new models of care delivery such as telephone triage, referral triage, self-management support, care coordination, case management and care planning. He supports commissioners and providers to develop new programmes of care. His clinical interests include primary care, frail elderly, care planning, self-care support, GP access, patient leadership and shared decision making.
